160 related articles for article (PubMed ID: 25663875)
1. CD14
Liu J; Zhou Y; Huang Q; Qiu L
Oncol Lett; 2015 Mar; 9(3):1167-1172. PubMed ID: 25663875
[TBL] [Abstract][Full Text] [Related]
2. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
[TBL] [Abstract][Full Text] [Related]
3. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs.
Jitschin R; Braun M; Büttner M; Dettmer-Wilde K; Bricks J; Berger J; Eckart MJ; Krause SW; Oefner PJ; Le Blanc K; Mackensen A; Mougiakakos D
Blood; 2014 Jul; 124(5):750-60. PubMed ID: 24850760
[TBL] [Abstract][Full Text] [Related]
4. Monocytic MDSC as a source of immunosuppressive cytokines in chronic lymphocytic leukemia (CLL) microenvironment.
Kowalska W; Bojarska-Junak A
Folia Histochem Cytobiol; 2020; 58(1):25-36. PubMed ID: 32227331
[TBL] [Abstract][Full Text] [Related]
5. Increased circulating CD14(+)HLA-DR-/low myeloid-derived suppressor cells are associated with poor prognosis in patients with small-cell lung cancer.
Tian T; Gu X; Zhang B; Liu Y; Yuan C; Shao L; Guo Y; Fan K
Cancer Biomark; 2015; 15(4):425-32. PubMed ID: 25792471
[TBL] [Abstract][Full Text] [Related]
6. Circulating CD14(+)HLA-DR(-/low) myeloid-derived suppressor cell is an indicator of poor prognosis in patients with ESCC.
Huang H; Zhang G; Li G; Ma H; Zhang X
Tumour Biol; 2015 Sep; 36(10):7987-96. PubMed ID: 25967454
[TBL] [Abstract][Full Text] [Related]
7. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
8. A novel subset of B7-H3
Zhang G; Huang H; Zhu Y; Yu G; Gao X; Xu Y; Liu C; Hou J; Zhang X
Oncoimmunology; 2015 Feb; 4(2):e977164. PubMed ID: 25949876
[TBL] [Abstract][Full Text] [Related]
9. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
10. High M-MDSC Percentage as a Negative Prognostic Factor in Chronic Lymphocytic Leukaemia.
Zarobkiewicz M; Kowalska W; Chocholska S; Tomczak W; Szymańska A; Morawska I; Wojciechowska A; Bojarska-Junak A
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32937740
[TBL] [Abstract][Full Text] [Related]
11. The study of CD14+HLA-DR-/low myeloid-drived suppressor cell (MDSC) in peripheral blood of peripheral T-cell lymphoma patients and its biological function.
Du J; Sun X; Song Y
Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):62-67. PubMed ID: 28466815
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.
Mougiakakos D; Jitschin R; von Bahr L; Poschke I; Gary R; Sundberg B; Gerbitz A; Ljungman P; Le Blanc K
Leukemia; 2013 Feb; 27(2):377-88. PubMed ID: 22828446
[TBL] [Abstract][Full Text] [Related]
13. Circulating CD14
Gao XH; Tian L; Wu J; Ma XL; Zhang CY; Zhou Y; Sun YF; Hu B; Qiu SJ; Zhou J; Fan J; Guo W; Yang XR
Hepatol Res; 2017 Sep; 47(10):1061-1071. PubMed ID: 27764536
[TBL] [Abstract][Full Text] [Related]
14. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I
Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472
[TBL] [Abstract][Full Text] [Related]
15. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.
Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A
J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of CD14
Chen Y; Pan G; Tian D; Zhang Y; Li T
Oncol Lett; 2017 Jul; 14(1):349-354. PubMed ID: 28693175
[TBL] [Abstract][Full Text] [Related]
17. [The expression and association of CD14(+) HLA-DR(Low/-) myeloid-derived suppressor cell-like cells and interleukin-1β in ovarian cancer].
Wang HY; Zhao R; Ren H; Zou MJ; Zhang J; Zhang Y
Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2663-2669. PubMed ID: 28910953
[No Abstract] [Full Text] [Related]
18. CD33
Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
[TBL] [Abstract][Full Text] [Related]
19. Galectin-9 and myeloid-derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia.
Alimu X; Zhang J; Pang N; Zhang R; Chen R; Zeng X; Tudahong S; Chen G; Muhashi M; Zhao F; Ding J; Qu J
Immun Inflamm Dis; 2023 May; 11(5):e853. PubMed ID: 37249287
[TBL] [Abstract][Full Text] [Related]
20. HLA-G expression as a prognostic indicator in B-cell chronic lymphocytic leukemia.
Attia MA; Nosair NA; Gawally A; Elnagar G; Elshafey EM
Acta Haematol; 2014; 132(1):53-8. PubMed ID: 24557341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
